471 related articles for article (PubMed ID: 22964643)
1. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
Lok BH; Carley AC; Tchang B; Powell SN
Oncogene; 2013 Jul; 32(30):3552-8. PubMed ID: 22964643
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers.
Hamid AB; Frank LE; Bouley RA; Petreaca RC
PLoS One; 2022; 17(9):e0273736. PubMed ID: 36107942
[TBL] [Abstract][Full Text] [Related]
3. Rad52 inactivation is synthetically lethal with BRCA2 deficiency.
Feng Z; Scott SP; Bussen W; Sharma GG; Guo G; Pandita TK; Powell SN
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):686-91. PubMed ID: 21148102
[TBL] [Abstract][Full Text] [Related]
4. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement.
Lok BH; Powell SN
Clin Cancer Res; 2012 Dec; 18(23):6400-6. PubMed ID: 23071261
[TBL] [Abstract][Full Text] [Related]
6. PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Zhang F; Ma J; Wu J; Ye L; Cai H; Xia B; Yu X
Curr Biol; 2009 Mar; 19(6):524-9. PubMed ID: 19268590
[TBL] [Abstract][Full Text] [Related]
7. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.
Hromas R; Kim HS; Sidhu G; Williamson E; Jaiswal A; Totterdale TA; Nole J; Lee SH; Nickoloff JA; Kong KY
Breast Cancer Res; 2017 Nov; 19(1):122. PubMed ID: 29145865
[TBL] [Abstract][Full Text] [Related]
8. BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer.
Foo TK; Xia B
Cancer Res; 2022 Sep; 82(18):3191-3197. PubMed ID: 35819255
[TBL] [Abstract][Full Text] [Related]
9. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
Cramer-Morales K; Nieborowska-Skorska M; Scheibner K; Padget M; Irvine DA; Sliwinski T; Haas K; Lee J; Geng H; Roy D; Slupianek A; Rassool FV; Wasik MA; Childers W; Copland M; Müschen M; Civin CI; Skorski T
Blood; 2013 Aug; 122(7):1293-304. PubMed ID: 23836560
[TBL] [Abstract][Full Text] [Related]
10. Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains.
Siaud N; Barbera MA; Egashira A; Lam I; Christ N; Schlacher K; Xia B; Jasin M
PLoS Genet; 2011 Dec; 7(12):e1002409. PubMed ID: 22194698
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.
Park JY; Singh TR; Nassar N; Zhang F; Freund M; Hanenberg H; Meetei AR; Andreassen PR
Oncogene; 2014 Oct; 33(40):4803-12. PubMed ID: 24141787
[TBL] [Abstract][Full Text] [Related]
12. Requirement of heterogeneous nuclear ribonucleoprotein C for BRCA gene expression and homologous recombination.
Anantha RW; Alcivar AL; Ma J; Cai H; Simhadri S; Ule J; König J; Xia B
PLoS One; 2013; 8(4):e61368. PubMed ID: 23585894
[TBL] [Abstract][Full Text] [Related]
13. Replication Protein A Phosphorylation Facilitates RAD52-Dependent Homologous Recombination in BRCA-Deficient Cells.
Carley AC; Jalan M; Subramanyam S; Roy R; Borgstahl GEO; Powell SN
Mol Cell Biol; 2022 Feb; 42(2):e0052421. PubMed ID: 34928169
[TBL] [Abstract][Full Text] [Related]
14. PALB2 is an integral component of the BRCA complex required for homologous recombination repair.
Sy SM; Huen MS; Chen J
Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7155-60. PubMed ID: 19369211
[TBL] [Abstract][Full Text] [Related]
15. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.
Zhang F; Fan Q; Ren K; Andreassen PR
Mol Cancer Res; 2009 Jul; 7(7):1110-8. PubMed ID: 19584259
[TBL] [Abstract][Full Text] [Related]
16. Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
Al-Mugotir M; Lovelace JJ; George J; Bessho M; Pal D; Struble L; Kolar C; Rana S; Natarajan A; Bessho T; Borgstahl GEO
PLoS One; 2021; 16(3):e0248941. PubMed ID: 33784323
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells.
Du LQ; Du XQ; Bai JQ; Wang Y; Yang QS; Wang XC; Zhao P; Wang H; Liu Q; Fan FY
J Cancer Res Clin Oncol; 2012 May; 138(5):811-8. PubMed ID: 22274865
[TBL] [Abstract][Full Text] [Related]
18. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway.
Chun J; Buechelmaier ES; Powell SN
Mol Cell Biol; 2013 Jan; 33(2):387-95. PubMed ID: 23149936
[TBL] [Abstract][Full Text] [Related]
19. PALB2 regulates recombinational repair through chromatin association and oligomerization.
Sy SM; Huen MS; Zhu Y; Chen J
J Biol Chem; 2009 Jul; 284(27):18302-10. PubMed ID: 19423707
[TBL] [Abstract][Full Text] [Related]
20. PALB2 self-interaction controls homologous recombination.
Buisson R; Masson JY
Nucleic Acids Res; 2012 Nov; 40(20):10312-23. PubMed ID: 22941656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
